Prudential Financial Inc. reduced its position in Phibro Animal Health Corporation (NASDAQ:PAHC) by 37.1% during the third quarter, Holdings Channel reports. The fund owned 86,360 shares of the company’s stock after selling 50,940 shares during the period. Prudential Financial Inc. owned approximately 0.22% of Phibro Animal Health Corporation worth $2,347,000 at the end of the most recent reporting period.

Several other hedge funds have also recently modified their holdings of PAHC. BlackRock Advisors LLC boosted its stake in shares of Phibro Animal Health Corporation by 9.1% in the second quarter. BlackRock Advisors LLC now owns 528,851 shares of the company’s stock worth $9,868,000 after buying an additional 44,212 shares during the last quarter. Messner & Smith Theme Value Investment Management Ltd. CA boosted its stake in shares of Phibro Animal Health Corporation by 47.6% in the second quarter. Messner & Smith Theme Value Investment Management Ltd. CA now owns 39,573 shares of the company’s stock worth $739,000 after buying an additional 12,771 shares during the last quarter. Dynamic Technology Lab Private Ltd purchased a new stake in shares of Phibro Animal Health Corporation during the second quarter worth $314,000. Principal Financial Group Inc. boosted its stake in shares of Phibro Animal Health Corporation by 3.8% in the second quarter. Principal Financial Group Inc. now owns 131,421 shares of the company’s stock worth $2,452,000 after buying an additional 4,792 shares during the last quarter. Finally, Dimensional Fund Advisors LP boosted its stake in shares of Phibro Animal Health Corporation by 3.3% in the second quarter. Dimensional Fund Advisors LP now owns 335,191 shares of the company’s stock worth $6,255,000 after buying an additional 10,836 shares during the last quarter. Institutional investors and hedge funds own 47.24% of the company’s stock.

Institutional Ownership by Quarter for Phibro Animal Health Corporation (NASDAQ:PAHC)

Shares of Phibro Animal Health Corporation (NASDAQ:PAHC) opened at 28.75 on Friday. The company has a market cap of $1.13 billion, a price-to-earnings ratio of 15.05 and a beta of 1.39. Phibro Animal Health Corporation has a one year low of $16.80 and a one year high of $35.69. The firm has a 50-day moving average of $28.29 and a 200 day moving average of $24.73.

Phibro Animal Health Corporation (NASDAQ:PAHC) last issued its quarterly earnings results on Wednesday, November 9th. The company reported $0.36 earnings per share for the quarter, topping the consensus estimate of $0.34 by $0.02. The company earned $188 million during the quarter, compared to analysts’ expectations of $188.85 million. Phibro Animal Health Corporation had a net margin of 10.13% and a return on equity of 75.49%. The business’s quarterly revenue was up .5% on a year-over-year basis. During the same period last year, the business earned $0.44 EPS. Equities research analysts anticipate that Phibro Animal Health Corporation will post $1.41 EPS for the current year.

The firm also recently declared a quarterly dividend, which was paid on Wednesday, December 21st. Stockholders of record on Wednesday, November 30th were paid a dividend of $0.10 per share. The ex-dividend date was Monday, November 28th. This represents a $0.40 annualized dividend and a dividend yield of 1.39%. Phibro Animal Health Corporation’s dividend payout ratio is currently 21.05%.

COPYRIGHT VIOLATION WARNING: “Prudential Financial Inc. Has $2,347,000 Stake in Phibro Animal Health Corporation (PAHC)” was first posted by Watch List News and is owned by of Watch List News. If you are reading this story on another publication, it was illegally copied and reposted in violation of international trademark and copyright law. The legal version of this story can be accessed at http://www.watchlistnews.com/prudential-financial-inc-has-2347000-stake-in-phibro-animal-health-corporation-pahc/1061462.html.

A number of equities analysts recently issued reports on the stock. Macquarie lowered shares of Phibro Animal Health Corporation from a “neutral” rating to an “underperform” rating and set a $21.00 target price on the stock. in a research report on Friday, November 11th. Gabelli lowered shares of Phibro Animal Health Corporation from a “buy” rating to a “hold” rating in a research report on Thursday, November 10th. TheStreet raised shares of Phibro Animal Health Corporation from a “hold” rating to a “buy” rating in a research report on Friday, September 30th. Piper Jaffray Companies assumed coverage on shares of Phibro Animal Health Corporation in a research report on Thursday, December 15th. They set an “overweight” rating and a $32.00 target price on the stock. Finally, Zacks Investment Research raised shares of Phibro Animal Health Corporation from a “strong sell” rating to a “hold” rating in a research report on Wednesday, November 2nd. Three analysts have rated the stock with a sell rating, two have issued a hold rating and four have given a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus price target of $27.67.

In other news, SVP Thomas G. Dagger sold 1,700 shares of the firm’s stock in a transaction that occurred on Tuesday, December 20th. The shares were sold at an average price of $30.03, for a total transaction of $51,051.00. Following the completion of the transaction, the senior vice president now directly owns 200 shares of the company’s stock, valued at approximately $6,006. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, COO Larry Lee Miller sold 1,540 shares of the firm’s stock in a transaction that occurred on Tuesday, December 20th. The stock was sold at an average price of $30.04, for a total transaction of $46,261.60. Following the transaction, the chief operating officer now directly owns 252 shares of the company’s stock, valued at $7,570.08. The disclosure for this sale can be found here. Insiders own 48.09% of the company’s stock.

About Phibro Animal Health Corporation

Phibro Animal Health Corporation is an animal health and mineral nutrition company. The Company is engaged in developing, manufacturing and marketing products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. The Company operates through three segments: Animal Health, Mineral Nutrition and Performance Products.

5 Day Chart for NASDAQ:PAHC

Want to see what other hedge funds are holding PAHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Phibro Animal Health Corporation (NASDAQ:PAHC).

Receive News & Ratings for Phibro Animal Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.